CompletedN/Aketamine

Effects of S-ketamine on Perioperative Opioid Consumption

Sponsored by Erasme University Hospital

NCT ID
NCT07528651
Target Enrollment
53 participants
Start Date
2021-06-07
Est. Completion
2022-06-21

About This Study

This study is a triple-blind randomized controlled trial conducted at a tertiary care hospital in Brussels. It investigates whether a single dose of S-ketamine can reduce opioid (morphine) consumption in the first 24 hours after elective laparoscopic gynecological surgery in relatively healthy adult patients (ASA 1-2). The goal is to assess S-ketamine's effectiveness within a standardized postoperative pain management protocol.

Conditions Studied

Pain ManagementPostoperative PainOpioid Consumption, PostoperativeOpioid Analgesia

Interventions

  • Esketamine at low dose
  • Saline (0.9% NaCl)

Eligibility

Sex:FEMALE
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria:

* Adult patients American Society of Anesthesiologists (ASA) physical status classification I or II
* Scheduled for elective laparoscopic gynecological surgery

Exclusion Criteria:

* Body mass index (BMI) \> 30 kg/m²
* Known allergy to any drugs used in the study
* Chronic pain patients or regular use of analgesics
* Pregnant or breastfeeding patients

Study Locations (1)

Erasme Hospital
Brussels, Brussels Capital, Belgium

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source